Antibody ofPredetermined Specificity toa Carboxy-Terminal Region ofH-rasGeneProducts Inhibits Their Guanine Nucleotide- Binding Function (original) (raw)

Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines

Jun Fujita

Urological Research, 1988

View PDFchevron_right

Antisense inhibition of ras p21 expression that is sensitive to a point mutation

Kathleen Pirollo

Biochemistry, 1991

View PDFchevron_right

Ras p21 proteins with high or low GTPase activity can efficiently transform NIH3T3 cells

Juan Carlos Lacal

Cell, 1986

View PDFchevron_right

ras gene Amplification and malignant transformation

Simonetta Pulciani

1985

View PDFchevron_right

Oligomeric structure of p21 ras proteins as determined by radiation inactivation

Eugenio Santos

Journal of Biological Chemistry, 1988

View PDFchevron_right

Activation of a human c-K-ras oncogene

Manuel Perucho

Nucleic Acids Research

View PDFchevron_right

The Pattern of Mutational Involvement of RAS Genes in Human Hematologic Malignancies Determined by DNA Amplification and Direct Sequencing

Martin Cline

Blood, 1990

View PDFchevron_right

Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy

H. Niman

Proceedings of the National Academy of Sciences, 1987

View PDFchevron_right

Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms

Ann Thor

Virchows Archiv B Cell Pathology Including Molecular Pathology, 1988

View PDFchevron_right

Expression of p21/sup ras/ in normal and malignant human tissues: lack of association with proliferation and malignancy

H. Niman

Pnas, 1987

View PDFchevron_right

RAS ONCOGENES IN THE DIAGNOSIS OF HUMAN TUMOURS

George Sourvinos

View PDFchevron_right

Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation

Channing Der

Molecular and Cellular Biology

View PDFchevron_right

P21-RAS Effector Domain Mutants Constructed by "Cassette" Mutagenesis

Berthe Willumsen

Molecular and Cellular Biology, 1988

View PDFchevron_right

Nuclear Ras: Unexpected subcellular distribution of oncogenic forms

Monika Chabicovsky

Journal of Cellular Biochemistry, 2001

View PDFchevron_right

Ras P21 Deletion Mutants and Monoclonal Antibodies as Tools for Localization of Regions Relevant to P21 Function

Juan Carlos Lacal

Proceedings of the National Academy of Sciences, 1986

View PDFchevron_right

Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes

David Goeddel

Cell, 1987

View PDFchevron_right

Inhibition of Ras oncogenic activity by Ras protooncogenes

Roberto Diaz

International Journal of Cancer, 2005

View PDFchevron_right

Malignant Activation of a K-ras Oncogene in Lung Carcinoma but not in Normal Tissue of the Same Patient

Giuseppe della Porta

Science, 1984

View PDFchevron_right

Activation of a human c-K- ras oncogeoe

Manuel Perucho

Nucleic Acids Research, 1984

View PDFchevron_right

Structure of the carboxyl terminus of the RAS gene-encoded P21 proteins

Matthew Pincus

Proceedings of the National Academy of Sciences, 1988

View PDFchevron_right

ras p21 oncoprotein expression in human colonic neoplasia?an immunohistochemical study with monoclonal antibody RAP-5

Giovanni Lanza

Histopathology, 1988

View PDFchevron_right

Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells

audrey chang

Proceedings of the National Academy of Sciences, 1984

View PDFchevron_right

Enhanced Expression of c-Ha-ras p21 in Human Stomach Adenocarcinomas Defined by Immunoassays Using Monoclonal Antibodies and in Situ Hybridization

Ann Thor

Cancer Research, 1987

View PDFchevron_right

Complex effects of Ras proto-oncogenes in tumorigenesis

Roberto Christian Díaz

Carcinogenesis, 2003

View PDFchevron_right

Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinoma defined by immunoassays using monoclonal antibodies and in-situ hibridization

Ann Thor

Cancer Research

View PDFchevron_right

Signal transduction. Prelude to an anniversary for the RAS oncogene

Julian Downward

View PDFchevron_right

The role of the RAS oncogene in the formation of tumours

Penny Gilbert

Journal of Cell Science, 1988

View PDFchevron_right

Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP

Ann Thor

Virchows Archiv B Cell Pathology Including Molecular Pathology, 1988

View PDFchevron_right

H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism

Javier León

Oncogene, 2000

View PDFchevron_right

Enhanced Expression of e-1la-ras p21 in Human Stomach Adenocarcinomas Defined by Immunoassays Using Monoclonal Antibodies and in Situ Hybridization

Renato Mariani-Costantini

View PDFchevron_right

Ras p21 Farnesylation in Ultraviolet B Radiation--Induced Tumors in The Skin of SKH-1 Hairless Mice

Sikandar Abbas

Journal of Investigative Dermatology, 1994

View PDFchevron_right